US 8470888
Botryllamides and method of inhibiting PGP in a mammal afflicted with cancer
granted A61KA61K31/165A61K31/277
Quick answer
US patent 8470888 (Botryllamides and method of inhibiting PGP in a mammal afflicted with cancer) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jun 20 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jun 25 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 20 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K31/165, A61K31/277, A61K31/353, A61P